A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Kineta Inc.
Chinese University of Hong Kong
Royal Marsden NHS Foundation Trust
Petra Pharma
Gruppo Oncologico del Nord-Ovest
China International Medical Foundation
Azienda Ospedaliero-Universitaria Careggi
Assistance Publique - Hôpitaux de Paris
Luzitin SA
National Cancer Institute (NCI)
National Cancer Institute (NCI)
McMaster University
National Cancer Institute (NCI)
Medical University Innsbruck